Cobalt Ferrite Nanoparticles for Tumor Therapy: Effective Heating versus Possible Toxicity

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Materials Science

Background:

• Magnetic nanoparticles (MNPs) are promising for cancer therapy, specifically magnetic hyperthermia (MHT).
• Optimization focuses on minimizing MNP toxicity while maximizing heating efficiency for MHT.
• Cobalt ferrite MNPs are being explored for their potential in targeted cancer treatments.

Purpose of the Study:

• To evaluate the biocompatibility and toxicity of 12 nm cobalt ferrite MNPs in rodents.
• To assess the magnetic properties and heating capabilities of these MNPs for MHT applications.
• To determine the suitability of cobalt ferrite MNPs for effective and safe tumor therapy.

Main Methods:

• Intraperitoneal injection of varying dosages of citrate-functionalized cobalt ferrite MNPs into mice and rats.
• 30-day monitoring of animal weight, behavior, blood cell counts, and biochemical parameters.
• Histological examination of organs and assessment of MNP magnetic properties in tumor tissue.

Main Results:

• Cobalt ferrite MNPs exhibited no toxic effects at concentrations relevant for MHT.
• Specific Loss Power (SLP) of approximately 400 W g^-1 was achieved, indicating high heating efficiency.
• MNPs maintained magnetic properties within tumor tissue over multiple MHT cycles.

Conclusions:

• Citrate-functionalized cobalt ferrite MNPs are a safe and effective platform for MHT-based cancer therapy.
• These MNPs provide efficient heating without significant organism toxicity.
• This research supports the development of smaller MNPs with sustained heating efficiency for future cancer treatments.